Transcode Therapeutics

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-4
-13
-51
284
EBITDA
-4,845
-4,263
-12,034
-21
EBIT
-4,850
-4,276
-12,085
-148
Net Income
-4,856
-4,276
-12,085
-2,351
Net Change In Cash
0
0
0
0
Free Cash Flow
-4,083
-4,194
-3,097
-3,146
Cash
2,835,916
7,374
11,569
5,811
Basic Shares
833
833
172
356

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-534
-516
-98
-42
EBITDA
-16,193
-17,973
-17,466
-6,705
EBIT
-16,728
-18,490
-17,564
-6,748
Net Income
-16,754
-18,546
-17,564
-6,843
Net Change In Cash
0
0
0
0
Free Cash Flow
-13,357
-18,110
-15,863
-5,521
Cash
5,811
2,767
4,968
20,825
Basic Shares
356
5
16
16

Earnings Calls

QuarterEPS
2025-09-30
-$5.82
2025-06-30
-$5.13
2025-03-31
-$1,286.15
2024-12-31
-$1,286.14